EyePoint, Inc. EYPT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.71M-8.7% | $101.82M+2.1% | $74.58M-6.6% | $71.14M-21.6% | $85.16M-68.6% | ||
| $144.83M-37.8% | $204.27M-24.7% | $129.45M-25.6% | $184.59M-2.6% | $233.04M+722% | ||
| $150K0.0% | $150K0.0% | $150K0.0% | $150K0.0% | $150K0.0% | ||
| $1.16M+162% | $651K+7.2% | $1.05M+176% | $625K-54.5% | $442K-85.3% | ||
| $1.25M-41.3% | $1.81M-21.3% | $2.11M-24.8% | $2.68M-27.1% | $2.13M-50.0% | ||
| $24.55M+295% | $20.11M+112% | $8.93M-22.8% | $6.22M-35.5% | $6.22M-43.9% | ||
| $249.5M-23.7% | $328.66M-14.3% | $216.11M-19.5% | $265.25M-10.1% | $326.98M+2.9% | ||
| $9.48M+17.9% | $9.02M+10.3% | $8.86M+5.6% | $8.76M+27.0% | $8.04M+20.5% | ||
| $19.78M-8.1% | $20.22M-3.7% | $20.66M-3.5% | $21.09M-5.3% | $21.51M+357% | ||
| $9.3M+58.3% | $5.95M+1.9% | $5.92M+144% | $5.9M— | $5.88M— | ||
| $288.22M-20.5% | $364M-13.0% | $251.7M-16.4% | $301.15M-7.1% | $362.56M+10.1% | ||
| $18.81M+14.6% | $10.49M-10.5% | $10.08M+37.2% | $19.69M+37.7% | $16.42M+132% | ||
| $2.21M+12.3% | $2.14M+48.6% | $2.08M+61.0% | $2.01M+78.1% | $1.97M+66.4% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $2.08M+17.9% | $2.02M+62.1% | $1.96M+65.1% | $1.9M+68.1% | $1.77M+61.0% | ||
| $37.46M-10.1% | $37.02M-24.5% | $30.09M-38.3% | $33.18M-46.6% | $41.68M-33.4% | ||
| —— | —— | —— | —— | —— | ||
| $20.23M-9.3% | $20.77M-5.0% | $21.3M-2.8% | $21.82M-1.6% | $22.31M+383% | ||
| $22.31M-7.3% | $22.79M-1.3% | $23.26M+0.7% | $23.72M+1.8% | $24.08M+321% | ||
| $55K-68.9% | $87K-57.6% | $118K-49.4% | $148K— | $177K— | ||
| $57.75M-10.0% | $57.88M-29.4% | $51.51M-37.3% | $55.14M-42.5% | $64.17M-19.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $83K+20.3% | $83K+22.1% | $70K+32.1% | $69K+32.7% | $69K+38.0% | ||
| $1.42B+16.8% | $1.41B+16.7% | $1.24B+17.9% | $1.22B+18.7% | $1.22B+19.1% | ||
| -$1.19B-29.6% | -$1.1B-26.6% | -$1.04B-24.7% | -$977.64M-21.9% | -$918.21M-19.0% | ||
| $802K-13.1% | $961K-6.5% | $919K-21.5% | $832K+5.1% | $923K+10.4% | ||
| $230.47M-22.8% | $306.11M-9.0% | $200.18M-8.5% | $246.01M+7.8% | $298.4M+19.4% | ||
| $288.22M-20.5% | $364M-13.0% | $251.7M-16.4% | $301.15M-7.1% | $362.56M+10.1% | ||
| $144.83M-37.8% | $204.27M-24.7% | $129.45M-25.6% | $184.59M-2.6% | $233.04M+722% | ||
| $9.3M+58.3% | $5.95M+1.9% | $5.92M+144% | $5.9M— | $5.88M— | ||
| $19.78M-8.1% | $20.22M-3.7% | $20.66M-3.5% | $21.09M-5.3% | $21.51M+357% | ||
| $19.78M-8.1% | $20.22M-3.7% | $20.66M-3.5% | $21.09M-5.3% | $21.51M+357% | ||
| $9.3M+58.3% | $5.95M+1.9% | $5.92M+144% | $5.9M— | $5.88M— | ||
| $19.78M-8.1% | $20.22M-3.7% | $20.66M-3.5% | $21.09M-5.3% | $21.51M+357% | ||
| $9.3M+58.3% | $5.95M+1.9% | $5.92M+144% | $5.9M— | $5.88M— | ||
| $16.44M-9.6% | $24.39M+34.8% | $17.94M+26.7% | $11.48M-14.0% | $18.18M+14.0% | ||
| $16.44M-9.6% | $24.39M+34.8% | $17.94M+26.7% | $11.48M-14.0% | $18.18M+14.0% | ||
| $2.21M+12.3% | $2.14M+48.6% | $2.08M+61.0% | $2.01M+78.1% | $1.97M+66.4% | ||
| $22.31M-7.3% | $22.79M-1.3% | $23.26M+0.7% | $23.72M+1.8% | $24.08M+321% | ||
| $1.42B+16.8% | $1.41B+16.7% | $1.24B+17.9% | $1.22B+18.7% | $1.22B+19.1% | ||
| $83K+20.3% | $83K+22.1% | $70K+32.1% | $69K+32.7% | $69K+38.0% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are EyePoint, Inc. 's total assets?
- EyePoint, Inc. (EYPT) holds $288.2M in total assets, down 20.5% year over year.
- How much debt does EyePoint, Inc. have?
- EyePoint, Inc. carries $22.3M in total debt against $230.5M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does EyePoint, Inc. have?
- EyePoint, Inc. holds $77.7M in cash and equivalents.
- Can EyePoint, Inc. cover its short-term obligations?
- Its current ratio is 6.66 — current assets exceed current liabilities.
- Where does EyePoint, Inc. 's balance sheet data come from?
- Every line is extracted from EyePoint, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
